• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ EXT ENTERIC BACTERIAL PANEL; GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ EXT ENTERIC BACTERIAL PANEL; GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM Back to Search Results
Catalog Number 443812
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/08/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that during use of bd max¿ ext enteric bacterial panel, a vibrio false positive patient result was obtained.There was no report of patient impact.
 
Additional Manufacturer Narrative
Investigation summary: the complaint investigation for discrepant results when using the bd max¿ extended enteric bacterial panel (xebp) assay (ref.(b)(4)) kit lot 5231261 was performed by the review of manufacturing records, review of customer¿s data and by the complaint¿s history review.The review of quality control records of bd max¿ xebp lot 5231261 revealed no anomalies that could explain the customer¿s discrepant results.Customer questioned the positive vibrio results for four samples processed on bd max¿ instrument (b)(6): run 92 (a2), run 93 (a6), run 95 (b5), and run 100 (a10), obtained in a short period of time (from february 6th to 8th).Pcr curve adjudication of the vibrio positive samples revealed late and low but appearing to be true vibrio positive amplifications.Low positives samples, such as the ones investigated herein can occur due to bacterial titers in the specimen being at or near the limit of detection of the assay or through environmental or cross contamination introduced during the sample preparation at the customer¿s site.The total rate of positive vibrio samples for the current complaint kit lot 5231261 is (b)(4) (15/2383) while the rate of all other lots , used by the customer, is (b)(4) (6/835), suggesting the reagent is not suspected to be an issue.Nevertheless, manual curve adjudication has limitations; visual examination of pcr curves for low signal is a conservative assessment of the data.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max xebp assay lot 5231261.The root cause was not identified.However, specimens at or near the assay limit of detection (lod), as well as environmental or cross contamination could explain the customer¿s discrepant result.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action since no new hazard was identified.
 
Event or Problem Description
It was reported that during use of bd max¿ ext enteric bacterial panel, a vibrio false positive patient result was obtained.There was no report of patient impact.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ EXT ENTERIC BACTERIAL PANEL
Common Device Name
GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer Contact
matt j. connor
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key24547079
Report Number3007420875-2026-00050
Device Sequence Number9272073
Product Code PCH
UDI-Device Identifier00382904438128
UDI-Public(01)00382904438128(17)270220(10)5231261
Combination Product (Y/N)N
Initial Reporter CountrySF
PMA/510(K) Number
K214122
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number443812
Device Lot Number5231261
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/13/2026
Supplement Date Received by Manufacturer03/18/2026
Initial Report FDA Received Date03/09/2026
Supplement Report FDA Received Date03/26/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/19/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-